Ali-Osman F, Maurer H R
J Cancer Res Clin Oncol. 1983;106(1):17-20. doi: 10.1007/BF00399892.
Several tumors are characterized by elevated levels of polyamines involved in vital cell proliferation processes. Polyamine oxidases (PAO), present in ruminant and particularily in fetal calf serum (FCS), degrade polyamines to polyaminoaldehydes and other products that inhibit cell proliferation. Since most in vitro assays for cloning tumor stem cells use FCS as an essential supplement of the nutrient media, we examined the effects of specifically inhibiting the PAO activity on the clonal growth of leukemic cells and the following normal lymphocytes: the W 25 rat chloroleukemia, the M1 mouse myeloblastic and the L 1210 rat lymphoblastic leukemia, a primary human acute myeloblastic leukemia (AML) and acute lymphocytic leukemia (ALL) as well as normal human PHA-stimulated lymphocytes. In the presence od horse serum, nontoxic doses of the PAO inhibitor 1-hydroxybenzyloxyamine did not affect colony growth of either cell type. However, in the presence of FCS, clonal growth of W 25, ALL, AML, and PHA lymphocytes was significantly stimulated by the enzyme inhibitor. Our data suggest (a) that poor cell proliferation of several tumors in vitro may result from the reaction of polyamines (from cells) and PAO (from serum), (b) that this can be easily tested by means of a specific PAO inhibitor, and (c) that the growth conditions can be optimized by adding nontoxic doses of the enzyme inhibitor or by exchanging FCS for another serum.
几种肿瘤的特征是参与重要细胞增殖过程的多胺水平升高。存在于反刍动物尤其是胎牛血清(FCS)中的多胺氧化酶(PAO),可将多胺降解为多氨基醛和其他抑制细胞增殖的产物。由于大多数用于克隆肿瘤干细胞的体外试验都使用FCS作为营养培养基的必需补充剂,我们研究了特异性抑制PAO活性对白血病细胞以及以下正常淋巴细胞克隆生长的影响:W 25大鼠氯白血病、M1小鼠髓母细胞白血病和L 1210大鼠淋巴细胞白血病、原发性人类急性髓细胞白血病(AML)和急性淋巴细胞白血病(ALL)以及正常人PHA刺激的淋巴细胞。在存在马血清的情况下,无毒剂量的PAO抑制剂1-羟基苄氧基胺不会影响任何一种细胞类型的集落生长。然而,在存在FCS的情况下,该酶抑制剂可显著刺激W 25、ALL、AML和PHA淋巴细胞的克隆生长。我们的数据表明:(a)几种肿瘤在体外细胞增殖不佳可能是由于(细胞中的)多胺与(血清中的)PAO反应所致;(b)这可以通过一种特异性PAO抑制剂轻松检测;(c)通过添加无毒剂量的酶抑制剂或用另一种血清替代FCS,可以优化生长条件。